Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
Clinical trial NCT05183854 · RECRUITING
Trial details
- NCT number
- NCT05183854
- Sponsor
- University of Utah
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2027-03-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.